Met could transcriptionally down-regulated the expression of MDR1 by modulating AMPK/mTOR pathway and inhibiting HIF-1α expression, leading to reverse multidrug resistance in hepatocellular carcinoma [31]. This evidence concerns the gene MTOR and hepatocellular carcinoma.